rs749033513
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_183050.4(BCKDHB):c.503G>A(p.Arg168His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R168C) has been classified as Pathogenic.
Frequency
Consequence
NM_183050.4 missense
Scores
Clinical Significance
Conservation
Publications
- maple syrup urine disease type 1BInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, G2P, Myriad Women’s Health
- maple syrup urine diseaseInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- classic maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intermittent maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thiamine-responsive maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BCKDHB | NM_183050.4 | c.503G>A | p.Arg168His | missense_variant | Exon 5 of 10 | ENST00000320393.9 | NP_898871.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BCKDHB | ENST00000320393.9 | c.503G>A | p.Arg168His | missense_variant | Exon 5 of 10 | 1 | NM_183050.4 | ENSP00000318351.5 | ||
| BCKDHB | ENST00000356489.9 | c.503G>A | p.Arg168His | missense_variant | Exon 5 of 11 | 1 | ENSP00000348880.5 | |||
| BCKDHB | ENST00000369760.8 | c.503G>A | p.Arg168His | missense_variant | Exon 5 of 6 | 3 | ENSP00000358775.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461846Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 727224 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Maple syrup urine disease Pathogenic:3
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 168 of the BCKDHB protein (p.Arg168His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with maple syrup urine disease (PMID: 16786533, 26232051, 28197878; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 457149). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BCKDHB protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.
Variant summary: BCKDHB c.503G>A (p.Arg168His) results in a non-conservative amino acid change located in the Transketolase-like, pyrimidine-binding domain (IPR005475) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251412 control chromosomes (gnomAD). c.503G>A has been reported in the literature in both homozygous and compound heterozygous individuals affected with Maple Syrup Urine Disease (e.g., Rodriguez-Pombo_2006, Couce_2015, Su_2017). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in <1% BCKD activity in homozygous patient cells (e.g., Rodriguez-Pombo_2006). The following publications have been ascertained in the context of this evaluation (PMID: 26232051, 16786533, 28197878). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic (n = 2) or likely pathogenic (n = 1). Additionally, another missense variant impacting the same amino acid, c.502C>T (p.R168C), has been classified as pathogenic by our lab. Based on the evidence outlined above, the variant was classified as pathogenic.
Maple syrup urine disease type 1B Pathogenic:2
Maple syrup urine disease type 1A Pathogenic:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at